Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort.

RMD Open · 2022 · PMC9639158 · PMID 36328401

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Similar to skin fibrosis, we could consistently see a tendency towards a benefit of tocilizumab therapy for lung fibrosis as measured by FVC per cent predicted, which did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.